You don't have an account?
CREATE AN ACCOUNT.

React® HyPerVital

React^® HyPerVital contains a number of ingredients to:⁴

Reinforce the normal function of the immune system: folic acid, b-carotene, vitamins B6, B12 and D,
Protect cells from oxidative stress: folic acid⁵, b-carotene, glutathione⁶, acetyl coenzyme Q10⁷, SOD⁸
Support normal steroid hormone synthesis and metabolism as well as hormonal activity regulation: Vit Β5 and Vit Β6, respectively.

Product features

Vitamins, minerals, trace elements and stem cells!
6 ingredients to fortify the immune system.
6 antioxidant ingredients in a single dose.
High-concentration boosting ingredients.
Convenient drinkable sachet format.
Excellent taste.
Developed and manufactured in Greece.

Benefits

B-carotene and vitamin E: dietary intake of b-carotene

and vitamin E is inversely proportional to the risk of

developing cervical cancer.⁹

Folic acid: its low levels are associated with an increased risk of cervical cancer.⁵
Acetyl Coenzyme Q10: plasma concentrations of coenzyme Q10 and vitamin E are inversely proportional to epithelial lesions.⁶
Glutathione: major antioxidant for somatic and germ cells.⁷

Each pack contains 30 drinkable sachets promising great taste

GREEK PRODUCT

National Organization for Medicines (EOF) Notification Number: 114569/29-9-2025
The notification number assigned by EOF is not equivalent to a marketing authorization by EOF

_
References1. Kyrgiou M, Koliopoulos G, Martin-Hirsch P, Arbyn M, Prendiville W, Paraskevaidis E. Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis. Lancet 2006; 367(9509): 489-98.
2. Arbyn M, Kyrgiou M, Simoens C, Raifu AO, Koliopoulos G, Martin-Hirsch P, Prendiville W, Paraskevaidis E. Perinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: meta-analysis. BMJ 2008; 337: a1284.
3. Founta C, Arbyn M, Valasoulis G, Kyrgiou M, Tsili A, Martin-Hirsch P, Dalkalitsis N, Karakitsos P, Kassanos D, Prendiville W, Loufopoulos A, Paraskevaidis E. Proportion of excision and cervical healing after large loop excision of the transformation zone for cervical intraepithelial neoplasia. BJOG 2010; 117(12): 1468-74.
4. Kyrgiou M, Mitra A, Arbyn M, Stasinou SM, Martin-Hirsch P, Bennett P, Paraskevaidis E. Fertility and early pregnancy outcomes after treatment for cervical intraepithelial neoplasia: systematic review and meta-analysis. BMJ 2014; 349: g6192.
5. Kyrgiou M, Mitra A, Arbyn M, Paraskevaidi M, Athanasiou A, Martin-Hirsch PP, Bennett P, Paraskevaidis E. Fertility and early pregnancy outcomes after conservative treatment for cervical intraepithelial neoplasia. Cochrane Database Syst Rev 2015; 2015(9): CD008478.
6. Kyrgiou M, Valasoulis G, Stasinou SM, Founta C, Athanasiou A, Bennett P, Paraskevadis E. Proportion of cervical excision for cervical intraepithelial neoplasia as a predictor of pregnancy outcomes. Int J Gynaecol Obstet 2015; 128(2): 141-7.
7. Kyrgiou M, Athanasiou A, Paraskevaidi M, Mitra A, Kalliala I, Martin-Hirsch P, Arbyn M, Bennett P, Paraskevaidis E. Adverse obstetric outcomes after local treatment for cervical preinvasive and early invasive disease according to cone depth: systematic review and meta-analysis. BMJ 2016; 354: i3633.
8. Kyrgiou M, Mitra A, Paraskevaidis E. Fertility and Early Pregnancy Outcomes Following Conservative Treatment for Cervical Intraepithelial Neoplasia and Early Cervical Cancer. JAMA Oncol 2016; 2(11): 1496-8.
9. Kyrgiou M, Athanasiou A, Kalliala IEJ, Paraskevaidi M, Mitra A, Martin-Hirsch PP, Arbyn M, Bennett P, Paraskevaidis E. Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease. Cochrane Database Syst Rev 2017; 11(11): CD012847.
10. Paraskevaidis E, Athanasiou A, Paraskevaidi M, Bilirakis E, Galazios G, Kontomanolis E, Dinas K, Loufopoulos A, Nasioutziki M, Kalogiannidis I, Athanasiadis A, Papanikolaou A, Vatopoulou A, Grimbizis G, Tsolakidis D, Daponte A, Valasoulis G, Gritzeli S, Michail G, Adonakis G, Paschopoulos M, Tsonis O, Anaforidou ME, Batistatou A, Kyrgiou M, HeCPA Group. Cervical Pathology Following HPV Vaccination in Greece: A 10-year HeCPA Observational Cohort Study. In Vivo 2020; 34(3): 1445-9.
11. Athanasiou A, Veroniki AA, Efthimiou O, Kalliala I, Naci H, Bowden S, Paraskevaidi M, Arbyn M, Lyons D, Martin-Hirsch P, Bennett P, Paraskevaidis E, Salanti G, Kyrgiou M. Comparative effectiveness and risk of preterm birth of local treatments for cervical intraepithelial neoplasia and stage IA1 cervical cancer: a systematic review and
network meta-analysis. Lancet Oncol 2022; 23(8): 1097-108.
12.Paraskevaidis E, Athanasiou A, Ellis LB, Bowden SJ, Kyrgiou M. Individualised care for cervical precancer. BMJ 2025; 388: r7.

Συστατικά	Ποσότητα ανά 10ml φακελίσκο	Συνιστώμενη Ημερήσια ∆όση
Apple root extract	100μg	**
B-Carotene 10%	100mg	**
Coenzyme Q10	40mg	**
Cooper (as gluconate)	140μg	45,6%*
Folic Acid	800μg	400%*
Kelp	20mg	**
L-Glutathione	300mg	**
Marigold Extract	100μg	**
Pine bark extract	600μg	**
Black pepper extract	50μg	**
Rhodiola rosea extract	100μg	**
Rose Extract	1μg	**
Astaxanthin	3mg	**
SOD	1μg	**
Selenium (as sodium)	25.08μg	45.6%*
Vitamin B1	1.78mg	162%*
Vitamin B5	5.98mg	100%*
Vitamin B6	2.22mg	156%*
Vitamin B12	2.76μg	110%*
Vitamin D3	2000IU	1000%
Vitamin E succianate	24.3mg	202.5%
Zinc (as gluconate)	7.9mg	79%
Vitamin K2 (menaquinone-7)	200μg	267%*

Other ingredients: Xanthan gum, Sodium Hydroxide, Potassium Sorbate, Sodium Benzoate, Sucralose, Banana Flavor.

Instructions for Use:

To be consumed once (1) daily, dissolved in a glass of water during meals or according to your doctor’s/pharmacist’s instructions. Do not exceed recommended dosage.
Storage instructions:

To be kept in a cool and dry place (<25°C) and away from children. Dietary supplements should not be used as a substitute for a varied and balanced diet. This product is not intended to diagnose, treat, cure, or prevent any disease.
For allergens see ingredients.